Acorda Therapeutics (ACOR) Tops Q1 EPS by 18c
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total other expense (net): -4.54M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q1 EPS of $0.36, $0.18 better than the analyst estimate of $0.18. Revenue for the quarter came in at $71.25 million versus the consensus estimate of $70.95 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
